Share

GSK helps research for malaria cure

British drug maker GlaxoSmithKline (GSK) is to make thousands of chemical compounds that have the potential to cure malaria available for research, a newspaper has reported.

Andrew Witty, GSK chief executive, told the Guardian newspaper that multinational drug companies must balance social responsibility with their need to make profits to please shareholders.

Firms had "an imperative to earn the trust of society, not just by meeting expectations but by exceeding them," he said.

The company will publish details of 13 500 chemical compounds from its library that have the potential to act against the parasite that causes deadly malaria in sub-Saharan Africa, the Guardian said.

13 500 new opportunities to start research

In a major speech in New York, Witty will also announce an eight-million-dollar (4.9-million-pound, 5.6-million-euro) fund to pay for scientists to investigate the chemicals, according to the paper.

"I think it is a significant contribution to give scientists around the world 13 500 new opportunities to start research," Witty said. "It is trying to create a permissiveness around scientific research in an area where we know the marketplace isn't going to stimulate massive research," he added.

The drug company chief said it was an opportunity to get thousands of researchers involved in the fight against malaria. It is a development on a speech almost a year ago by Witty, when he vowed to put all drugs for neglected diseases in a so-called "patent pool", waiving intellectual property rights so any
researcher could examine them, the Guardian reported.

Aid groups Oxfam and Medecins sans Frontieres gave the announcement a cautious welcome. - (Sapa, January 2010)

We live in a world where facts and fiction get blurred
Who we choose to trust can have a profound impact on our lives. Join thousands of devoted South Africans who look to News24 to bring them news they can trust every day. As we celebrate 25 years, become a News24 subscriber as we strive to keep you informed, inspired and empowered.
Join News24 today
heading
description
username
Show Comments ()
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE